Moneycontrol
HomeNewsTrendsCurrent AffairsAsiatic lion dies of COVID-19 in Tamil Nadu zoo; second death in a month
Trending Topics

Asiatic lion dies of COVID-19 in Tamil Nadu zoo; second death in a month

Since the detection of the infection among animals, the zoo management has been involved in hectic efforts to prevent its spread among other animals.

June 16, 2021 / 17:56 IST
Story continues below Advertisement
Representative image (Source: Shutterstock)

Another lion at the Arignar Anna Zoological Park (AAZP) in Vandalur, succumbed to SARS-CoV-2 on Wednesday morning.

Confirming the death of the Asiatic male lion named Pathbanathan, aged 12 years, Deputy Director of AAZP said the lion was housed in the safari area of the park.

Story continues below Advertisement

"Samples of the said lion had tested positive for SARS- CoV-2 as per the report of National Institute of High Security Animal Diseases (NIHSAD), Bhopal, communicated on June 3. The lion has been under intensive treatment since then," he said in a statement.

This is the second tragedy that struck the zoo which lost a nine-year-old lioness Neela due to Coronavirus on June 3.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show